Transcriptomics

Dataset Information

0

Expression data from CD4+ and CD11c+ cells from DO11.10 RAG2-/- mice


ABSTRACT: Abatacept is a recombinant CTLA-4 moleculed fused to a mutated human IgG molecule, which is clinically used in rheumatoid arthritis by inhibiting CD28-costimulation. This study aimed to inverstigate the ability of abatacept -mediated costimulation blockade to induce antigen-specific tolerance during primary immune responses. This is important as some studies have suggested that costimulation blockade can lead to CD4+ T cell anergy which could be beneficial for early therapy of autoimmune diseases such as rheumatoid arthritis. In addition we also investigated the effect that abatacept has on CD11c+ antigen presenting cells. This is important as costimulation blocakde can affect the biderectional interaction between CD4+ T cells and CD11c+ cells influencing the immunological outcome. We used microarrays to identify if abatacept treatment leads to antigen specific anergy using transgenic animals and models of priming and oral tolerance that established a synchronised monoclonal response. In addition this magnified the effect on the CD11c+ antigen presenting cells.

ORGANISM(S): Mus musculus

PROVIDER: GSE62089 | GEO | 2014/10/07

SECONDARY ACCESSION(S): PRJNA263176

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2014-10-07 | E-GEOD-62089 | biostudies-arrayexpress
2023-04-10 | GSE224842 | GEO
| PRJNA722354 | ENA
2021-10-12 | GSE178245 | GEO
2017-05-17 | E-GEOD-68215 | biostudies-arrayexpress
2020-07-01 | GSE151161 | GEO
2017-05-17 | GSE68215 | GEO
2020-07-24 | GSE91079 | GEO
2011-09-09 | E-GEOD-32021 | biostudies-arrayexpress
2023-06-30 | GSE216679 | GEO